featured
A New Prognostic Model in Patients With Advanced Urothelial Carcinoma Treated With First-Line Lmmune Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Urology Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A New Prognostic Model in Patients With Advanced Urothelial Carcinoma Treated With First-Line Immune Checkpoint Inhibitors
Eur Urol Oncol 2021 Jan 07;[EPub Ahead of Print], AR Khaki, A Li, LN Diamantopoulos, NJ Miller, L Carril-Ajuria, D Castellano, I De Kouchkovsky, V Koshkin, J Park, A Alva, MA Bilen, T Stewart, V Santos, N Agarwal, J Jain, Y Zakharia, R Morales-Barrera, M Devitt, A Nelson, CJ Hoimes, E Shreck, BA Gartrell, A Sankin, A Tripathi, R Zakopoulou, A Bamias, A Rodriguez-Vida, A Drakaki, S Liu, V Kumar, MP Lythgoe, DJ Pinato, J Murgic, A Fröbe, M Joshi, P Isaacsson Velho, N Hahn, L Alonso Buznego, I Duran, M Moses, P Barata, MD Galsky, G Sonpavde, EY Yu, V Shankaran, GH Lyman, P GrivasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.